I bet it will be priced at where it closed ($29.74)just like with ARWR a few weeks back. As everyone knows, normally these things are priced at a discount but with the white hot RNA market we are in, I wouldn't be surprised if it went off at a premium, although that is a long shot. I would be surprised if it went off at anything less than today's close since ARWR just did a secondary a few weeks ago and they priced it at the closing price the day before. Just a few more hours to see where she prices but there is no way I would be selling in the pre market tomorrow but if you wanted to buy, it might be a good time since some sold in AH today at less than the closing priced due to the offering announcement. I predict a nice pop tomorrow just like ARWR did when they announced they didn't have to sell at a discount. GLTA.
b14, the fact they haven't issued a pr is not surprising to me only because as I posted over on the Google board, I spoke with Mike Gray last month and he told me they had no intention of issuing a press release upon the filing with the FDA. I told him how wrong I thought that was and he said he would pass it along but the earliest we would probably find out is possibly next week. He said they may be making some presentations surrounding the JP Morgan conference (but not at the conference) beginning on the 13th and they would probably be updating the slide deck which would contain updated status on 427, that is if they actually file by then. I have no idea if they filed or not and I am very ticked off they decided to keep this very material news to themselves. Please contact management and express your dissatisfaction.